Download by
Scanning QR Code
CN Stock MarketDetailed Quotes
603456 Zhejiang Jiuzhou Pharmaceutical
Watchlist
26.90
-0.37-1.36%
Market Closed 09/26 15:00 CST
27.34High26.77Low38.10KlotVolume
27.27Open27.27Pre Close102.80MTurnover0.43%Turnover Ratio22.51P/E (TTM)24.20BMarket Cap47.7652wk High26.27P/E (Static)899.49MShares24.2852wk Low3.01P/B24.14BFloat Cap62.35Historical High30.00Limit Up897.57MShs Float3.59Historical Low24.54Limit Down2.09%Amplitude18.63KlotAsk0.40Dividend TTM26.98Avg Price18.05KlotBid1.49%Div YieldTTM100Lot Size
Zhejiang Jiuzhou Pharmaceutical News
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the completion of commercial and commercial change registration for wholly-owned subsidiaries
Announcement of Resolutions of the 37th Meeting of the Seventh Board of Directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Independent opinions of independent directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on matters relating to the 37th meeting of the 7th board of directors
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on adjusting the repurchase price of restricted stocks
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the repurchase of restricted stocks that have been granted to some of the incentive targets for cancellation of shares that have been granted but not yet unlocked
Legal opinion of Zhejiang Tianze Law Firm on matters relating to the repurchase and cancellation of some restricted shares and unlocking of certain restricted shares by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (2020 Equity Incentive Plan)
Legal opinion of Zhejiang Tianze Law Firm on matters relating to the repurchase and cancellation of some restricted shares by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (2022 Equity Incentive Plan)
Announcement of Resolutions of the 27th Meeting of the Seventh Board of Supervisors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to notify creditors of the repurchase and cancellation of some restricted shares
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the unlocking and listing of part of the third phase of restricted shares granted by the company\'s 2020 incentive plan
Announcement of Resolutions of the 26th Meeting of the 7th Board of Supervisors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Verification opinion of Huatai United Securities Co., Ltd. on the use of part of the funds raised by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to increase capital for fundraising project implementers to carry out fund-raising projects
Independent opinions of independent directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on matters relating to the 36th meeting of the 7th board of directors
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on using part of the funds raised to increase capital for fundraising project implementers to implement fund-raising projects
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on early return of raised funds
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on completing the registration of commercial and commercial changes
On August 15, 2023, the company received a telephone survey from some institutional investors. For details, please see the attachment.
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the progress of establishing a wholly-owned subsidiary in Singapore
Summary of the 2023 semi-annual report of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Semi-Annual Report